Maria A. Lopez Olivo, M.D., M.Sc., Ph.D.

Peer-Reviewed Articles

1. Siddhanamatha HR, Heung E, Lopez-Olivo MLA, Abdel-Wahab N, Ojeda-Prias A, Willcockson I, Leong A, Suarez-Almazor ME. Quality assessment of websites providing educational content for patients with rheumatoid arthritis. Semin Arthritis Rheum 46(6):715-723, 2017. e-Pub 2017. PMID: 28258768.
2. Chhatwal J, He T, Hur C, Lopez-Olivo MA. Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving. Clin Gastroenterol Hepatol 15(6):827-837.e8, 2017. e-Pub 2016. PMID: 27650326.
3. Zamora NV, Christensen R, Goel N, Klokker L, Lopez-Olivo MA, Kristensen LE, Carmona L, Strand V, Curtis JR, Suarez-Almazor ME. Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report. J Rheumatol, 2017. e-Pub 2017. PMID: 28620065.
4. Pundole X, Cheema HI, Petitto GS, Lopez-Olivo MA, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis. Bone Marrow Transplant 52(5):663-670, 2017. e-Pub 2017. PMID: 28112742.
5. Lopez-Olivo MA, Ingleshwar A, Volk RJ, Jibaja-Weiss M, Barbo A, Saag K, Leong A, Suarez-Almazor ME. Development and Pilot Testing of Multimedia Patient Education Tools for Patients with Knee Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis. Arthritis Care Res (Hoboken), 2017. e-Pub 2017. PMID: 28464546.
6. Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Maxwell LJ, Buchbinder R, Lopez-Olivo MA, Suarez-Almazor ME, Tugwell P, Wells GA. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev 3:CD012591, 2017. e-Pub 2017. PMID: 28282491.
7. Pan X, Lopez-Olivo MA, Song J, Pratt G, Suarez-Almazor ME. Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis. BMJ Open 7(3):e013242, 2017. e-Pub 2017. PMID: 28249848.
8. Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 25(14):1520-1531, 2016. e-Pub 2016. PMID: 27060064.
9. Volk RJ, Linder SK, Lopez-Olivo MA, Kamath GR, Reuland DS, Saraykar SS, Leal VB, Pignone MP. Patient Decision Aids for Colorectal Cancer Screening: A Systematic Review and Meta-analysis. Am J Prev Med 51(5):779-791, 2016. e-Pub 2016. PMID: 27593418.
10. Bruera S, Barbo AG, Lopez-Olivo MA. Use of medication reminders in patients with rheumatoid arthritis. Rheumatol Int 36(11):1543-1548, 2016. e-Pub 2016. PMID: 27590013.
11. Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev(5):CD004525, 2013. e-Pub 2013. PMID: 23728649.
12. Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases. Cancer Treat Rev 39(1):97-104, 2013. e-Pub 2012. PMID: 22898302.
13. Lopez-Olivo MA, Andrabi TR, Palla SL, Suarez-Almazor ME. Cervical spine radiographs in patients with rheumatoid arthritis undergoing anesthesia. J Clin Rheumatol 18(2):61-6, 2012. PMID: 22334269.
14. Lopez-Olivo MA, Landon GC, Siff SJ, Edelstein D, Pak C, Kallen MA, Stanley M, Zhang H, Robinson KC, Suarez-Almazor ME. Psychosocial determinants of outcomes in knee replacement. Ann Rheum Dis 70(10):1775-81, 2011. e-Pub 2011. PMID: 21791452.
15. Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis: a cochrane systematic review. J Rheumatol 38(1):10-20, 2011. e-Pub 2010. PMID: 20952462.
16. Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME. A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29(9):947-55, 2010. e-Pub 2010. PMID: 20383550.
17. Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev 7(7):CD008331, 2010. e-Pub 2010. PMID: 20614469.
18. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugwell P. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a cochrane overview. CMAJ 181(11):787-96, 2009. e-Pub 2009. PMID: 19884297.
19. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev(4):CD007848, 2009. e-Pub 2009. PMID: 19821440.
20. Maillefert JF, Kloppenburg M, Fernandes L, Punzi L, Günther KP, Martin Mola E, Lohmander LS, Pavelka K, Lopez-Olivo MA, Dougados M, Hawker GA. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP). Osteoarthritis Cartilage 17(10):1293-6, 2009. e-Pub 2009. PMID: 19410033.
21. Aguilar-Chavez EA, Gamez-Nava JI, Lopez-Olivo MA, Galvan-Melendres S, Corona-Sanchez EG, Loaiza-Cardenas CA, Celis A, Cardona-Muñoz EG, Gonzalez-Lopez L. Circulating leptin and bone mineral density in rheumatoid arthritis. J Rheumatol 36(3):512-6, 2009. e-Pub 2009. PMID: 19208597.
22. Roundtree AK, Kallen MA, Lopez-Olivo MA, Kimmel B, Skidmore B, Ortiz Z, Cox V, Suarez-Almazor ME. Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol 62(2):128-37, 2009. e-Pub 2008. PMID: 19013763.
23. Corona-Sanchez EG, Gonzalez-Lopez L, Muñoz-Valle JF, Vazquez-Del Mercado M, Lopez-Olivo MA, Aguilar-Chavez EA, Salazar-Paramo M, Loaiza-Cardenas C, Oregon-Romero E, Navarro-Hernandez RE, Gamez-Nava JI. Circulating e-selectin and tumor necrosis factor-alpha in extraarticular involvement and joint disease activity in rheumatoid arthritis. Rheumatol Int 29(3):281-6, 2009. e-Pub 2008. PMID: 18726101.
24. Lopez-Olivo MA, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum 59(11):1625-38, 2008. PMID: 18975351.
25. Gonzalez-Lopez L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Cota-Sanchez AR, Lopez-Olivo MA, Villa-Manzano AI, Ortega-Flores R, Espinoza-Magaña GL, Rojo-Contreras W, Cardona-Muñoz EG, Gamez-Nava JI. Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables. Rheumatol Int 28(12):1223-8, 2008. e-Pub 2008. PMID: 18719918.
26. Gossec L, Jordan JM, Mazzuca SA, Lam MA, Suarez-Almazor ME, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert JF, OARSI-OMERACT task force "total articular replacement as outcome measure in OA". Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task force. Osteoarthritis Cartilage 16(7):742-8, 2008. e-Pub 2008. PMID: 18417373.
27. Villa-Manzano AI, Gamez-Nava JI, Salazar-Paramo M, Valera-Gonzalez IC, Garcia-Gonzalez A, Garcia-Gonzalez G, Morales-Romero J, Lopez-Olivo A, Galvan-Ramirez LM, Ruiz-Ruvalcaba R, Cardona-Muñoz EG, Gonzalez-Lopez L. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus. Rheumatol Int 26(8):712-6, 2006. e-Pub 2005. PMID: 16231121.
28. Lopez-Olivo MA, Gonzalez-Lopez L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz EG, Gamez-Nava JI. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35(2):112-6, 2006. PMID: 16641044.
29. Morales-Romero J, Cázares-Méndez JM, Gámez-Nava JI, Triano-Páez M, Villa-Manzano AI, López-Olivo MA, Rodríguez-Arreola BE, González-López L. [Patterns of health care in an out patient rheumatologic clinic]. Reumatol Clin 1(2):87-94, 2005. e-Pub 2008. PMID: 21794243.
30. des Bordes J, Suarez-Almazor ME, Volk RJ, Lu H, Edwards B, Lopez-Olivo MA. Development and testing of an educational website on promoting bone health in cancer survivors. J Health Comm.
31. He T, Lopez-Olivo MA, Hur C, Chhatwal J. Cost-Effectiveness of Direct-Acting Antivirals for Treatment of Hepatitis C Genotypes 2-6. Alimentary Pharmacology & Therapeutics.

Invited Articles

1. Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME. Adalimumab: eight years of experience in rheumatoid arthritis. International Journal of Clinical Rheumatology 8(2):165-84, 2013.
2. Lopez-Olivo MA, Tayar JH. Safety concerns on the use of biologic drugs for the treatment of rheumatoid arthritis. CML Rhematology 31(4):101-16, 2012.
3. Lopez-Olivo MA, Suarez-Almazor ME. Developing guidelines in musculoskeletal disorders. Clin Exp Rheumatol 25(6 Suppl 47):28-36, 2007. PMID: 18021504.

Other Articles

1. Suarez-Almazor ME, Ortiz Z, Lopez-Olivo M, Moffett ML, Pak C, Skidmore B, Kimmel B, Kallen MA, Cox VL Infliximab and etanercept in rheumatoid arthritis: systematic review of long-term clinical effectiveness, safety, and cost-effectiveness. Canadian Agency for Drugs and Technologies in Health, 2007.
2. Suarez-Almazor ME, Ortiz Z, Lopez-Olivo M, Pak C, Skidmore B, Kimmel B, Kallen MA, Cox VL, Roundtree A Infliximab and etanercept in rheumatoid arthritis: timing, dose escalation, and switching. Canadian Agency for Drugs and Technologies in Health, 2007.
3. Suarez-Almazor ME, Ortiz Z, Lopez-Olivo M, Moffett ML, Pak C, Skidmore B, Kimmel B, Kallen MA, Cox VL Long-term clinical and cost-effectiveness of infliximab and etanercept for rheumatoid arthritis. Canadian Agency for Drugs and Technologies in Health, 2007.

Editorials

1. Lopez-Olivo MA, Tayar J, Suarez-Almazor ME. The updated guidelines on the use of rituximab in rheumatoid arthritis: Existing challenges and future opportunities. Rheumatology 50(12):2153-4, 2011.

Abstracts

1. Peddi P, Lopez-Olivo MA, Pratt G, Suarez-Almazor M. Denosumab in patients with cancer and skeletal metastases. Division of Internal Medicine Research Retreat, 2012.
2. Lopez-Olivo MA, Pratt G, Salahudeen A. Rasburicase for the treatment and prevention of tumor lysis sundrome in adults. Division of Internal Medicine Research Retreat, 2012.
3. Waimann CA, Fernandez-Mazarambroz RJ, Cantor S, Lopez-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Impact of slow recovery and poor functional outcomes on direct and indirect costs after total knee replacement in osteoarthritis patients. Arthritis Rheum 63(Suppl):S347, 2011.
4. Shah N, Pratt G, Suarez-Almazor M, Lopez-Olivo MA. Efficacy of bisphosphonates for bone metastases in patients with lung cancer: a systematic review and meta-analysis. Division of Internal Medicine Research Retreat, 2011.
5. Waimann CA, Fernandez-Mazarambroz RJ, Cantor S, Lopez-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Impact of psychosocial determinants on total knee replacement (TKR) costs: results from the patient expectations about knee surgery (PEAKS) cohort. Arthritis Rheum 63(Suppl):S345, 2011.
6. Lopez-Olivo MA, Kallen MA, Pak CH, Siff SJ, Landon GC, Edelstein D, Robinson KC, Suarez-Almazor ME. Using the patient generated index (PGI) to measure personalized quality of life (QoL) in patients undergoing total knee arthroplasty (TKA). Arthritis Rheum 62(Suppl):S74, 2010.
7. Lopez-Olivo MA, Tayar JH, Suarez-Almazor ME. Febuxostat for the treatment of chronic recurrent gout: a meta-analysis. Ann Rheum Dis 69(Suppl 3):608, 2010.
8. Lopez-Olivo, MA, Shaw Y, Suarez-Almazor ME. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. Arthritis Rheum 62(Suppl):S315, 2010.
9. Lopez-Olivo MA, Martinez-Lopez JA, Tayar JH, Polo Cueto J, Pollono EN, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: meta-analysis of controlled trials. Arthritis Rheum 62(Suppl):S171-2, 2010.
10. Marengo MF, Waimann CA, Lopez-Olivo MA, Looney C, Suarez-Almazor ME. Controversies in the use of acupuncture for osteoarthritis (OA): a systematic review of the quality and treatment features of randomized clinical trials (RCT). Arthritis Rheum 62(Suppl):S389-90, 2010.
11. Lopez-Olivo MA, Suarez-Almazor ME, Shaw Y. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. Ann Rheum Dis 69(Suppl3):642, 2010.
12. Lopez-Olivo MA, Martinez-Lopez JA, Polo Cueto J, Pollono EN, Gonzalez-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: meta-analysis of controlled trials. Division of Internal Medicine Research Retreat, 2010.
13. Lopez-Olivo MA, Kallen M, Pak C, Siff SJ, Landon GC, Edelstein D, Robinson KC, Zhang H, Suarez-Almazor ME. Psychosocial and educational barriers to surgical success after knee arthroplasty. Arthritis Rheum 60(Suppl 10), 2009.
14. Lopez-Olivo MA, Kallen MA, Pak C, Siff SJ, Landon GC, Edelstein D, Suarez-Almazor ME. Change of individual values among persons with total knee arthroplasty during the first six months of recovery, 2008.
15. Lopez-Olivo MA, Suarez-Almazor ME, Moffett ML. Economic evaluation of biologic therapies in ankylosing spondylitis: a systematic review. Ann Rheum Dis 66(Suppl II):274, 2007.
16. Suarez-Almazor ME, Lopez-Olivo MA, Pak CH, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: A systematic review of observational studies. Arthritis Rheum 56(Suppl 9), 2007.
17. Lopez-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky M, Ng B, Marcus D, Reveille JD. Treatment adherence and use of reminders in patients with rheumatic disease. Arthritis Rheum 56(Suppl 9), 2007.
18. Gossec L, Jordan JM, Mazzuca SM, Lam MA, Suarez-Almazor ME, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert JF, Groupe de travail OARSI-OMERACT. La mesure de l’interligne articulaire est un meilleur indice structural dans la gonarthrose que les scores semi-quantitatifs : étude comparative de 3 méthodes d’évaluation de l’arthrose dans 1759 radiographies. French Rheumatology Society, 2007.
19. Lopez-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky L, Ng B, Marcus D, Reveille JD. Effect of depression and social support on the self-reported adherence in patients with rheumatic diseases. Arthritis Rheum 56(Suppl 9), 2007.
20. Alcaraz-Lopez MF, Aguilar-Chavez EA, Sandoval-Ramirez L, Loaiza-Cardenas CA, Lopez-Olivo MA, Salazar-Paramo M, Davalos-Rodriguez IP, Martinez-Corral ME, Gamez-Nava JI , Gonzalez-Lopez L. Clinical, epidemiological factors and TAQI genotype of the vitamin D receptor in osteoporosis associated with rheumatoid arthritis. Ann Rheum Dis 66(Suppl II):591, 2007.
21. Lopez-Olivo MA, Andrabi TR, Suarez-Almazor ME. Cervical spine instability in patient with rheumatoid arthritis (RA) undergoing general surgery. Arthritis Rheum 56(Suppl 9), 2007.
22. Lopez-Olivo MA, Roundtree AK, Ortiz Z, Skidmore B, Suarez-Almazor ME. Switching between anti-TNF agents treatments for rheumatoid arthritis: a systematic review. Ann Rheum Dis 66(Suppl II):189, 2007.
23. Suarez-Almazor ME, Roundtree AK, Kallen MA, Lopez-Olivo MA, Ortiz Z, Skidmore B. Systematic review of reviews on the use of biologics for rheumatoid arthritis. Arthritis Rheum 56(Suppl 9), 2007.
24. Gonzalez-Lopez L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Villa-Manzano AI, Cota-Sánchez AR, Lopez-Olivo MA, Alonso-Gamiño L, Espinoza-Magaña GLC, Cardona-Muñoz EG, Rojo-Contreras EW, Gamez-Nava JI. Hyperhomocysteinemia in ankylosing spondylitis. Ann Rheum Dis 66(Suppl II):613, 2007.
25. Gossec L, Jordan JM, Lam M, Suarez-Almazor ME, Mazzuca S, Renner JB, Lopez-Olivo, MA, Hawker G, Dougados M, Maillefert J. Measurement of joint space width appears to be the most valid indicator of structural damage in knee osteoarthritis: a comparative study of 3 radiographic scores in 1759 x-rays. Ann Rheum Dis 66(Suppl II):58, 2007.
26. Suarez-Almazor ME, Lopez-Olivo MA, Pak C, Ortiz Z, Cox VL, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: a systematic review of observational studies. Ann Rheum Dis 66(Suppl II):601, 2007.
27. Lopez-Olivo MA, Moffett MM, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Economic evaluation of infliximab and etanercept: a systematic review. Ann Rheum Dis 65(Suppl II):329, 2007.
28. Lopez-Olivo MA, Roundtree AK, Skidmore B, Suarez-Almazor ME. A systematic review on the occurrence of cancer in patients with rheumatoid arthritis while on treatment of anti-TNF-α agents. Division of Internal Medicine Research Retreat(Abstract C3), 2007.
29. Lopez-Olivo MA, Kallen MA, Ortiz Z, Roundtree AK, Skidmore B, Suarez-Almazor ME. Scientific validity of clinical practice guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Arthritis Rheum 56(Suppl 9), 2007.
30. Lopez-Olivo MA, Kallen MA, Pak CH, Siff SJ, Landon GC, Eldestein D, Suarez-Almazor ME. Role of social support and depression on pain and function in patients undergoing total knee arthroplasty (TKA). Arthritis Rheum 56(Suppl 9), 2007.
31. Lopez-Olivo MA, Kallen M, Ortíz Z, Kendall Roundtree A, Skidmore B, Suárez-Almazor M. Validez científica de las guías de práctica clínica sobre el uso del infliximab, etanercept y adalimumab en artritis reumatoide. VI Jornada Nacional de la Sociedad Argentina para la Calidad en Atención de la Salud, 2007.
32. Lopez-Olivo MA, Garcia-Gonzalez A, Kallen MA, Richardson MN, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Social support and quality of life in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Arthritis Rheum 54((9):Suppl):S335-S336, 2006.
33. Corona-Sanchez EG, Gonzalez-Lopez L, Ayala-Lopez K, Aguilar-Chavez EA, Munoz-Valle F, Galvan-Melendez S, Loaiza-Cardenas C, Lopez-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Vazquez-Del Mercado M, Gamez-Nava JI. Levels of serum soluble E-selectin in active rheumatoid arthritis. Arthritis Rheum 54((9):Suppl):S379-S379, 2006.
34. Sanchez-Hernandez JD, Lopez-Olivo MA, Aguilar-Chavez E. Differences in the perception of health-related quality of life between men and women with ankylosing spondylitis. J Rheumatol 33((2):Suppl):408-408, 2006.
35. Alcaraz-Lopez MF, Gonzalez-Lopez L, Aguilar-Chavez E, Lopez-Olivo MA, Loaiza-Cardenas C, Gamez-Nava JI. Perfomance of Albrand index for identifying low bone density in rheumatoid arthritis. J Rheumatol 33((2):Suppl):408-409, 2006.
36. Aguilar-Chavez EA, Gonzalez-Lopez L, Lopez-Olivo MA, Galvan-Melendez S, Loaiza-Cardenas C, Alcaraz-Lopez MF, Gamez-Nava JI. Association between serum leptin levels and disease activity in rheumatoid arthritis. J Rheumatol 33((2):Suppl):409-409, 2006.
37. Aguilar-Chavez EA, Gonzalez-Lopez L, Lopez-Olivo MA, Alcaraz-Lopez MF, Corona-Sanchez EG, Galvan-Melendez S, Loaiza-Cardenas C, Varón-Villalpando E, Rojo-Contreras EW, Gamez-Nava JI. Association between serum leptin levels and disease activity in rheumatoid arthritis. Ann Rheum Dis 65(Suppl II):628, 2006.
38. Suarez-Almazor, ME, Lopez-Olivo MA, Kendall-Roundtree A, Ortiz Z, Skidmore B. Dose escalation in anti-tnf therapy for rheumatoid arthritis (ra) a systematic review. Ann Rheum Dis 65(Suppl II):603, 2006.
39. Lopez-Olivo MA, Moffett ML, Cox VL, Richardson MN, Garcia-Gonzalez A, Suarez-Almazor ME. Association of SF-6D health utilities with activity and side effects in patients with systemic lupus erythematosus. Arthritis Rheum 54((9):Suppl):S335-S336, 2006.
40. Lopez-Olivo MA, Ortiz Z, Pak CH, Cox V, Kimmel B, Kendall-Roundtree A, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing of therapeutic introduction of infliximab (IFX) and etanercept (ETN). Arthritis Rheum 54(Suppl):S243-S243, 2006.
41. Lopez-Olivo MA, Garcia-Gonzalez A, Kallen MA, Richardson MN, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Social support and quality of life in patients with rheumatoid arthritis. J Rheumatol 33((2):Suppl):422-423, 2006.
42. Lopez-Olivo MA, Ortiz Z, Pak CH, Cox V, Kimmel B, Kendall-Roundtree A, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing of therapeutic introduction of infliximab (ifx) and etanercept (etn). Ann Rheum Dis 65(Suppl II):329, 2006.
43. Lopez-Olivo MA, Moffett ML., Kallen MA., Ortiz Z., Skidmore B., Suarez-Almazor B.. Economic evaluation of infliximab and etarnercept: A sistematic review. Arthritis Rheum 54((9):Suppl):S336-S336, 2006.
44. Gamez-Nava JI, Corona-Sanchez E, Aguilar-Chavez E, Muñoz-Valle J, Galvan-Melendez S, Loaiza-Cardenas C, Lopez-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Rojo-Contreras E, Vazquez-Del Mercado M, Gonzalez-Lopez L. Serum-soluble e-selectin levels in active rheumatoid arthritis. Ann Rheum Dis 65(Suppl II):629, 2006.
45. Gamez-Nava, JI., Villa-Manzano, AI., Garcia-Gonzalez, A., Lopez-Olivo MA, Garcia-Gonzalez, G., Valera-Gonzalez, I., Salazar-Paramo, M., Morales-Romero, J., Gonzalez-Lopez, L.. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythermatosus. Arthritis Rheum 48((9):Suppl):1487, 2003.
46. Garcia-Gonzalez A, Villa-Manzano AI, Lopez-Olivo MA, Salazar-Páramo M, González-Valera I, Gámez-Nava JI, García-González G, Ornelas-Torres JC, Gonzalez-Lopez L, Cardona-Muñoz EG.. Comparison in serum levels of procollagen aminoterminal propeptides I and III in patients with systemic lupus erythematosus. Rev. Mex. Reumatol 18(29), 2003.
47. Romero Morales, J., Lopez Sandoval, I., Perez Serna JC, Lopez-Olivo MA, Villa Manzano, AI., Aguilar Chavez EAG., Gonzalez Lopez, L., Gamez Nava, JI.. Physician's behaviour regarding the use of alternative medicine in patients with rheumatoid arthritis. X Annual Meeting of the National Research Congress of Public Health, 2003.
48. Morales-Romero J, Lopez-Olivo MA, Villa-Manzano AI, García-González A, Hernandez-Romo JA, Gámez-Nava JI, Gonzalez-Lopez L.. Pain and perception of difficulty for the sexual relation: factors of risk for depression in rheumatoid arthritis. Rev. Mex. Reumatol 18(34), 2003.
49. Lopez-Olivo MA, Gonzalez-Lopez L, Gámez-Nava JI, Salazar-Páramo M, García-González A, Villa-Manzano AI, Cota Sánchez AR.. Serum homocysteine levels in patients with rheumatoid arthritis. Rev. Mex. Reumatol 18(52), 2003.

Book Chapters

1. Suarez-Almazor ME, Lopez-Olivo MA, Ortiz Z.. Epidemiología clínica de las enfermedades reumáticas. In: Reumatologia: Argentina, 2010.
2. Lopez-Olivo MA, Suarez-Almazor ME. Esclerosis sistemica y epidemiologia. In: Esclerosis Sistemica: Mexico, 2009.
3. Lopez-Olivo MA, Suarez-Almazor ME. Evaluaciones económicas de los antagonistas del factor de necrosis tumoral alfa en la espondilitis anquilosante. In: Espondilitis anquilosante y otras espondiloartritis. Permanyer Publications: Spain, 2009.
4. Lopez-Olivo MA, Suarez-Almazor ME. Costo-efectividad de la terapia biologica en las enfemedades reumaticas. In: Teraia biologica en las enfermedades reumaticas. Doyma Masson Publications: Spain, 2006.

Letters to the Editor

1. Gonzalez-Lopez L, Lopez-Olivo MA, Gamez-Nava JI. Relationship between homocysteine and body mass index in rheumatoid arthritis [Authors’ Reply to]. Scand J Rheumatol 36: 243-4, 2007.